Loading clinical trials...
Loading clinical trials...
A Phase III, Partially Modified Double-blind, Randomized, Parallel-group, Active-controlled, Multi-center Study to Compare the Immunogenicity and Describe the Safety of MenACYW Conjugate Vaccine and MENVEO® When Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in the United States
Conditions
Interventions
MenACYW conjugate vaccine
MenACYW-135 conjugate vaccine
+7 more
Locations
70
United States
Birmingham Pediatric Associates Site Number : 8400026
Birmingham, Alabama, United States
Southeastern Pediatric Associates Site Number : 8400003
Dothan, Alabama, United States
MedPharmics, LLC - Phoenix Site Number : 8400083
Phoenix, Arizona, United States
Northwest Arkansas Pediatric Clinic Site Number : 8400011
Fayetteville, Arkansas, United States
The Children's Clinic of Jonesboro, PA Site Number : 8400032
Jonesboro, Arkansas, United States
Emmaus Research Center, Inc Site Number : 8400031
Anaheim, California, United States
Start Date
April 25, 2018
Primary Completion Date
September 22, 2023
Completion Date
September 22, 2023
Last Updated
October 15, 2024
Lead Sponsor
Sanofi Pasteur, a Sanofi Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions